Mode
Text Size
Log in / Sign up

Guideline proposes AI tool for scoliosis measurement with cross-center validation

Guideline proposes AI tool for scoliosis measurement with cross-center validation
Photo by Ben Maffin / Unsplash
Key Takeaway
Consider AI measurement tools as potential screening aids in resource-limited settings, pending further validation.

This guideline presents a cross-center external validation study of SpineNET, a lightweight, interpretable keypoint-based AI framework built on the YOLOv13 paradigm for measuring Cobb angles in adolescent idiopathic scoliosis. The validation involved 1,200 radiographs for training/validation and 150 independent external test radiographs, with the AI tool compared against consensus measurements from three senior spine surgeons. The guideline focuses on the technical performance of this measurement-assisted tool rather than clinical outcomes or treatment recommendations.

Key findings from the validation include a Cobb angle mean absolute error (MAE) of 1.44°, an intraclass correlation coefficient (ICC) of 0.970, and minimal bias of 0.03°. The framework also demonstrated high object detection performance with mAP@50 of 94.2% and mAP@50-95 of 85.7%. These metrics suggest the AI tool can provide measurements comparable to expert surgeon consensus in this validation setting.

The authors note the tool could serve as an efficient and clinically interpretable measurement-assisted tool for high-throughput adolescent idiopathic scoliosis screening and follow-up in resource-constrained settings. However, the guideline does not report on safety outcomes, adverse events, or tolerability. Funding sources and conflicts of interest are also not reported, which limits assessment of potential biases.

For clinical practice, this guideline presents preliminary validation data for an AI measurement tool rather than treatment recommendations. The findings suggest potential utility for radiographic measurement assistance, but clinicians should interpret these results cautiously as they represent technical validation rather than clinical outcome evidence. Implementation would require consideration of local validation, integration with clinical workflows, and ongoing monitoring of measurement accuracy across diverse patient populations.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Adolescent idiopathic scoliosis (AIS) is routinely quantified on standing coronal radiographs using the Cobb angle; however, manual measurement is time-consuming and subject to intra-observer variability. We propose SpineNET, a lightweight, interpretable keypoint-based framework for automated scoliosis assessment on standing whole-spine posteroanterior (PA) radiographs. SpineNET is built on the YOLOv13 paradigm and enhances cross-scale structural modeling by replacing DS-C3k2 modules with Star-Blocks throughout the backbone and neck, while a lightweight shared-convolution detection head reduces redundancy across feature pyramid levels. The model is trained using only vertebral and pelvic bounding boxes and anatomical keypoints, without any Cobb angle supervision. During inference, Cobb angles as well as shoulder and pelvic coronal tilt angles are computed via a transparent keypoints-to-geometry pipeline with clinically auditable visual overlays. In a cross-center external validation (1,200 radiographs for training/validation and 150 independent external test radiographs), SpineNET achieved 94.2% mAP@50 and 85.7% mAP@50–95 with 1.7M parameters and 4.3B FLOPs. Compared with the consensus of three senior spine surgeons, SpineNET yielded a Cobb angle mean absolute error (MAE) of 1.44° and intraclass correlation coefficient (ICC) of 0.970, with minimal bias (0.03°) and narrow 95% limits of agreement. These results support SpineNET as an efficient and clinically interpretable measurement-assisted tool for high-throughput AIS screening and follow-up in resource-constrained settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.